November 25, 2024 November 25, 2024Categories From the Co-ChairsFrom the Co-Chairs, November 2024Fall Group Meeting highlights; impactful results in head and neck cancer; a ComboMATCH update
November 25, 2024 November 25, 2024Categories Special TopicsFall 2024 Group Meeting Focuses on Real-World Data, Innovation, and Health EquitySeveral themes emerged as key areas of focus for ECOG-ACRIN during the Fall 2024 Group Meeting
November 25, 2024 November 25, 2024Categories Special Topics54 Member Networks and Programs Receive Commendations in 2024 for Research PerformanceIn an annual evaluation, 54 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
November 25, 2024 November 25, 2024Categories Active Clinical TrialsTrial Spotlight: Zofia Piotrowska on the EA5162 Trial for Patients with Advanced Non-Small Cell Lung CancerEA5162 is testing a new therapy for certain patients with advanced NSCLC who have developed resistance to other treatments
October 17, 2024 October 17, 2024Categories From the Co-ChairsFrom the Co-Chairs, October 2024The co-chairs reflect on how the cancer research landscape has evolved over the last five years
October 17, 2024 October 17, 2024Categories PeopleRemembering William C. Wood, MDIn August, the cancer research community lost a leader in the fields of breast cancer and surgical oncology
October 17, 2024 October 17, 2024Categories Special TopicsPatient-Reported Outcomes Advisory Group Available as a Resource for ECOG-ACRIN InvestigatorsThe Patient-Reported Outcomes (PRO) Advisory Group guides study investigators on how best to include PRO measures and endpoints in clinical trials
October 17, 2024 October 17, 2024Categories Special TopicsCancer Cooperative Group Leaders Propose a Re-Engineering of the Nation’s Correlative Science Program for CancerThe Journal of Clinical Oncology has published a proposal to jump-start correlative research, which is almost at a standstill
October 17, 2024 October 17, 2024Categories Active Clinical TrialsAmended Trial: Robert Ferris Gives an Update on the EA3132 Trial for Patients with Head and Neck CancerThe changes aim to alleviate scheduling difficulties during the randomization step, and they introduce the new tumor test for this phase 2 trial testing radiotherapy with or without chemotherapy
October 17, 2024 October 17, 2024Categories Trial ResultsTrial Results: ECOG-ACRIN Research Round-UpSummaries of recently published ECOG-ACRIN research results